[1] 曹泽毅，郎景和，王临红，等. 中华妇产科学[M]. 3版.北京：人民卫生出版社，2014：2224-2242.[2] Khan AT，Shehmar M，Gupta JK.Uterine fibroids：current perspectives[J].Int J Womens Health，2014，6(6)：95-114.[3] Islam MS，Protic O，Stortoni P，et al. Complex networks of multiple factors in the pathogenesis of uterine leiomyoma[J]. Fertil Steril，2013，100(1)：178-193.[4] Munro MG，Critchley HOD，Broder MS，et al. The FIGO Classification System (“PALM-COEIN”) for causes of abnormal uterine bleeding in non-gravid women in the reproductive years，including guidelines for clinical investigation[J]. Int J Gynaecol Obstet，2011，113(1)：3-13.[5] 刘云嵘. 90年代绝经研究[M]．北京：人民卫生出版社，1998：11-12.[6] Peddada SD，Laughlin SK，Miner K，et al. Growth of uterine leiomyomata among premenopausal black and white women[J]. Proc Natl Acad Sci USA，2008，105(50)：19887-19892.[7] De Waay DJ，Syrop CH，Nygaard IE，et al. Natural history of uterine polyps and leiomyomata[J]. Obstet Gynecol，2002，100(1)：3-7.[8] Cramer SF，Marchetti C，Freedman J，et al. Relationship of myoma cell size and menopausal status in small uterine leiomyomas[J]. Arch Pathol Lab Med，2000，124(10)：1448-1453.[9] Templeman C，Marshall SF，Clarke CA，et al. Risk factors for surgically removed fibroids in a large cohort of teachers[J]. Fertil Steril，2009，92(4)：1436-1446.[10] Polatti F，Viazzo F，Colleoni R，et al. Uterine myoma in postmenopause：a comparison between two therapeutic schedules of HRT[J]. Maturitas，2000，37(1)：27-32.[11] Colacurci N，De Franciscis P，Cobellis L，et al. Effects of hormone replacement therapy on postmenopausal uterine myoma[J]. Maturitas，2000，35(2)：167-173.[12] Palomba S，Sena T，Noia R，et al. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas[J]. Obstet Gynecol，2001，98(6)：1053-1058.[13] Akkad AA，Habiba MA，Ismail N，et al. Abnormal uterine bleeding on hormone replacement：the importance of intrauterine structural abnormalities[J]. Obstet Gynecol，1995，86(3)：330-334.[14] Sayed GH，Zakherah MS，El-Nashar SA，et al. A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia[J]. Int J Gynaecol Obstet，2011，112(2)：126-130.[15] Magalh?es J，Aldrighi JM，de Lima GR. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas[J]. Contracept，2007，75(3)：193-198.[16] Friedman AJ，Rein MS，Harrison-Atlas D，et al. A randomized，placebo-controlled，double-blind study evaluating leuprolide acetate depot treatment before myomectomy[J]. Fertil Steril，1989，52(5)：728-733.[17] Bagaria M，Suneja AN，Guleria K，et al. Low-dose mifepristone in treatment of uterine leiomyoma：a randomized double-blind placebo-controlled clinical trial[J]. Aust N Z J Obstet Gynaecol，2009，49(1)：77-83.[18] Shen Q，Hua Y，Jiang W，et al. Effects of mifepristone on uterine leiomyoma in premenopausal women：a meta-analysis[J]. Fertil Steril，2013，100：1722-1726.[19] 贾柠伊，冯力民. AAGL子宫次全切除术的临床指南解读[J]. 国际妇产科学杂志，2014，41(5)：578-580.[20] 谢庆煌，柳晓春，郑玉华. 非脱垂子宫阴式子宫全切术的适应证和禁忌正探讨[J]. 中华妇产科杂志，2005，40(7)：441-444.[21] 李孟慧，冷金花，史精华，等. 腹腔镜与开腹子宫肌瘤剔除术后肌瘤残留、复发及妊娠结局的比较[J]. 中华妇产科杂志，2011，46(9)：669-673.[22] Rossetti A，Sizzi O，Soranna L，et al. Long -term results of laparoscopic myomectomy：recurrence rate incomparison with abdominal myomectomy[J]. Hum Reprod，2001，16 (4)：770-774.[23] Seracchioli R，Rossi S，Govoni F，et al．Fertility and obstetric outcome after laparoscopic myomectomy of large myomata：a randomized comparison with abdominal myomectomy[J]. Hum Reprod，2000，15(12)：2663-2668．[24] Wu F，Wang ZB，Zhu H，et al. Extracorporeal high intensity focused treatment for patients with breast cancer[J]. Breast Cancer Res Treat，2005，9（2）：51-60.[25] Cheung VYT. Sonographically guided high-intensity focused ultrasound for the management of uterine fibroids[J].J Ultrasound Med，2013，32(8)：1353-1358.[26] Bum PR，Mccall JM，Chinn RJ，et al．Uterine fibroleiomyoma：MR imaging appearances before and after embolization of uterine arteries[J]．Radiology，2000，214(3)：729-734．[27] Popovic M，Berzaczy D，Puchner S，et al．Long-term quality of life assessment in patients undergoing uterine fibroid embolization[J]. AJR，2009，193(1)：267-271. （2015-11-30收稿）
